KYMR
Price
$45.02
Change
+$1.78 (+4.12%)
Updated
Oct 11 closing price
25 days until earnings call
RXRX
Price
$6.62
Change
+$0.44 (+7.12%)
Updated
Oct 11 closing price
24 days until earnings call
Ad is loading...

KYMR vs RXRX

Header iconKYMR vs RXRX Comparison
Open Charts KYMR vs RXRXBanner chart's image
Kymera Therapeutics
Price$45.02
Change+$1.78 (+4.12%)
Volume$290.61K
CapitalizationN/A
Recursion Pharmaceuticals
Price$6.62
Change+$0.44 (+7.12%)
Volume$5.4M
CapitalizationN/A
View a ticker or compare two or three
KYMR vs RXRX Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
KYMR vs. RXRX commentary
Oct 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and RXRX is a StrongBuy.

COMPARISON
Comparison
Oct 13, 2024
Stock price -- (KYMR: $45.02 vs. RXRX: $6.62)
Brand notoriety: KYMR and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 70% vs. RXRX: 105%
Market capitalization -- KYMR: $3.14B vs. RXRX: $1.97B
KYMR [@Biotechnology] is valued at $3.14B. RXRX’s [@Biotechnology] market capitalization is $1.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, RXRX is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 5 bullish, 5 bearish.
  • RXRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both KYMR and RXRX are a good buy in the short-term.

Price Growth

KYMR (@Biotechnology) experienced а +4.55% price change this week, while RXRX (@Biotechnology) price change was +8.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 20, 2025.

RXRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.15B) has a higher market cap than RXRX($1.97B). KYMR YTD gains are higher at: 76.826 vs. RXRX (-32.860). KYMR has higher annual earnings (EBITDA): -152.44M vs. RXRX (-348.35M). KYMR has more cash in the bank: 510M vs. RXRX (474M). KYMR (88.2M) and RXRX (89.9M) have identical debt. KYMR has higher revenues than RXRX: KYMR (88.6M) vs RXRX (48.6M).
KYMRRXRXKYMR / RXRX
Capitalization3.15B1.97B160%
EBITDA-152.44M-348.35M44%
Gain YTD76.826-32.860-234%
P/E RatioN/AN/A-
Revenue88.6M48.6M182%
Total Cash510M474M108%
Total Debt88.2M89.9M98%
TECHNICAL ANALYSIS
Technical Analysis
KYMRRXRX
RSI
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bullish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 6 days ago
90%
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X63193.023000747.933600
+1.20%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with RXRX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+4.12%
RXRX - KYMR
51%
Loosely correlated
+7.12%
CRSP - KYMR
51%
Loosely correlated
+3.22%
NTLA - KYMR
50%
Loosely correlated
+4.44%
ACLX - KYMR
49%
Loosely correlated
+3.98%
EDIT - KYMR
48%
Loosely correlated
+7.77%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+7.12%
BEAM - RXRX
61%
Loosely correlated
+7.34%
NTLA - RXRX
58%
Loosely correlated
+4.44%
CRSP - RXRX
57%
Loosely correlated
+3.22%
PRME - RXRX
55%
Loosely correlated
+1.68%
KYMR - RXRX
51%
Loosely correlated
+4.12%
More